Estrogen receptor (ER) and thyroid hormone receptors (TRs) are ligand-dependent nuclear transcription factors that can bind to an identical half-site, AGGTCA, of their cognate hormone response elements. By in vitro transfection analysis in CV-1 cells, we show that estrogen induction of chloramphenicol acetyltransferase (CAT) activity in a construct containing a CAT reporter gene under the control of a minimal thymidine kinase (tk) promoter and a copy of the consensus ER response element was attenuated by cotransfection of TRal plus triiodothyronine treatment. This inhibitory effect of TR was ligand-dependent and isoformspecific. Neither TRfI1 nor TRf82 cotransfection inhibited estrogen-induced CAT activity, although both TRa and TRf8 can bind to a consensus ER response element. Furthermore, cotransfection of a mutated TRal that lacks binding to the AGGTCA sequence also inhibited the estrogen effect. Thus, the repression of estrogen action by liganded TRal may involve protein-protein interactions although competition of ER and TR at the DNA level cannot be excluded. A similar inhibitory effect of liganded TRal on estrogen induction of CAT activity was observed in a construct containing the preproenkephalin (PPE) promoter. A study in hypophysectomized female rats demonstrated that the estrogen-induced increase in PPE mRNA levels in the ventromedial hypothalamus was diminished by coadministration of triiodothyronine. These results suggest that ER and TR may interact to modulate estrogen-sensitive gene expression, such as for PPE, in the hypothalamus.
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Many genomic actions of estrogen or thyroid hormones [triiodothyronine (T3)] are mediated through the interactions of ligand-receptor complexes with DNA hormone response elements of target genes (1) (2) (3) . The consensus DNA sequences of estrogen response elements (ERE) and glucocorticoid response elements (GRE) comprise two major categories of DNA hormone response elements. It has been demonstrated, for example, that the glucocorticoid receptor and progesterone receptor can interact with the same DNA sequence, the GRE (1, 3) . Importantly, the half-site of a consensus ERE, AG-GTCA, is identical to that of a thyroid hormone response element (TRE), vitamin D response, and retinoic acid response elements, but functionally distinct from GRE (2) (3) (4) . Based on structural similarities, estrogen receptor (ER) and thyroid hormone receptor (TR) belong to the same nuclear receptor superfamily and provide an important model for receptor interactions. There are two major TR subtypes, TRa and TRf3, that are encoded by different genes (5, 6) . With alternative splicing, three functional isoforms, TRal, TR,B1, and TRj32, have been identified in mammalian systems. These TRs can bind to TRE as monomers, homodimers, and heterodimers (6) . In the present study, we have examined potential estrogen-thyroid hormone interactions on the regulation of estrogen-sensitive genes, such as for preproenkephalin (PPE), expressed in certain hypothalamic neurons.
MATERIALS AND METHODS
Plasmid Constructs. An expression vector for ER encoding the wild-type human ER in pSG5 plasmid was kindly provided by P. Chambon (Institut National de la Sante et de la Recherche Medicale, Strasbourg, France). Other vectors used in the experiments have been described before: pSG-TRa1 containing a rat wild-type TRal in pSG5X (7); TRa1-p containing a P-box mutated rat TRha in pSG5X (8) 13) , and nuclear protein extracts from dissected tissues were prepared by using conditions described (12, 14) . The concentrations of nuclear proteins were determined by the use of Bradford method (15) . Total cellular RNA from dissected VMH was extracted by use of TRIzol (Life Technologies, Grand Island, NY) following the manufacturer's instructions and the concentration was determined by UV absorbance. The levels of PPE mRNA were determined by using slot-blot hybridization with 32P-labeled PPE cDNA probe, were densitometrically analyzed in a Zenith soft laser densitometer (model SLR-2D/1D), and were normalized with oligo(dT)15 signals as previously described (13 (14) . Nuclear protein extracts or baculovirusexpressed TRal and TRl3 were incubated with DNA probe at room temperature at conditions as previously described (12, 14) . The DNA-protein complexes were separated on a 4% nondenaturing polyacrylamide gel (37.5:1 acrylamide/bis) with 5% glycerol by electrophoresis at room temperature. After electrophoresis, the gel was dried and exposed to Kodak X-Omat film with an intensifying screen at -70°C. For competition assays, the cold oligonucleotides were preincubated for 15 min before the addition of a probe. The supershift assay . L =. SL siSili .i1 ._. .E_L.
-S -E S --| . (Fig. 1B) with high affinity TREs, DR4 and F2H (17, 18) , and by supershift assay (Fig. 1C) Fig. 2, E2 (10-7 M) , in the presence of ER and ERE-tk-CAT, produced a significant induction of CAT activity, which was not altered by cotransfection of TRal alone. However, the addition of T3 (either 10-6 or 10-7 M) significantly decreased the estrogen induction of CAT activity when both ER and TRal were present. The addition of T3 alone without cotransfection of TRal did not affect the estrogen induction of CAT activity. The omission of the consensus ERE from the reporter construct failed to show any alterations in CAT activity compared with vehicle control when treated with either E2 or T3 in the cotransfection assay (data not shown). Thus, the estrogen effect is dependent on ER as well as ERE; the inhibition of estrogen induction of CAT activity by T3 requires ligand (T3)-receptor (TRal) interaction.
We next tested whether the binding of TRal to AGGTCA sequences is critical for the TRal inhibition of estrogen effect. Cotransfection of ER and ERE-tk-CAT with a P-box mutated TRal, which is incapable of binding to the AGGTCA sequence in the consensus TREs (8) , also displayed a liganddependent inhibition of estrogen-induced increase in CAT activity (Fig. 3) 
DISCUSSION
The nuclear thyroid/steroid receptor superfamily comprises a large number of proteins (1, 2, 19) , which share similarities in amino acid composition, protein structure, and cognate DNA recognition elements. Among these, the DNA binding domain of these receptors, a "zinc finger" structure, and their cognate DNA response elements can be divided to two major categories according to the core sequences. These are represented by GREs and EREs (1) . A challenge is to determine how these receptors in nerve cell nuclei regulate gene expression and related behavioral responses. Using estrogen-ER and T3-TR systems, we have studied the interactions of these nuclear receptors in the regulation of gene expression in vitro using cotransfection analysis. Also, we have studied hypothalamic PPE gene expression in intact animals as well as the regulation of behavioral responses such as lordosis in female rats [see the accompanying paper (20) ]. We show that thyroid hormone, T3, can inhibit estrogen-induced gene expression in cotransfection assays (see Fig. 2 ), similar to Glass et al. (21) and Segars et al. (22) . This inhibition is TR-dependent as well as EREdependent since in the absence of TRal, T3 does not affect estrogen-induced CAT activity (see Fig. 2 ). (17, 24) . Associated proteins related to ER and TR have been reported (25) (26) (27) (28) (29) , and a common coactivator for steroid hormone and thyroid hormone/retinoic acid receptors has recently been identified (30) . Whether the same coactivator is involved in the hypothalamic ER-TR interaction is currently under investigation. Strikingly, this T3-TR mediated inhibition of the estrogen effect is TR isoform-specific; it was only observed when TRal was cotransfected, but not TR/31 and TR,B2 (see Fig. 4 ). This TR isoform-specific action has been reported previously in other systems such as for TR interference of glucocorticoidmediated gene expression (31) . There are at least three functional isoforms of TR, TRal, TRj31, and TR,32, in mammalian systems (4, 6) generated by alternative promoter choice and RNA splicing of transcripts of two TR genes, TRa and TRf3. These TR isoforms have high homology in amino acid composition, especially in the DNA binding domain and hormone binding domain. The most diversified region between TRa isoforms and TRf3 isoforms is located in the N-terminal area, related to their trans-activation activity (4, 6) . Thus, further mutation analysis could identify the specific region of TRa responsible for the ligand-dependent TR inhibition of estrogen-ER-mediated gene expression.
The potential significance of ER-TR interactions on regulation of estrogen-sensitive promoters is exemplified by the study of PPE gene expression both in cotransfection assay and in intact animals, as well as by estrogen-induced lordosis behavior in female rats [see accompanying paper (20) ]. The PPE gene encodes enkephalin peptides that have been postulated to function as neuromodulators and have been implicated in estrogen-mediated female reproductive behavior (32) (33) (34) . We and others have demonstrated that estrogen can produce tissue-specific, sex-specific, and time-and dose-dependent induction of PPE gene expression in VMH of OVX female rats (35) (36) (37) that may be correlated with estrogen-induced lordosis behavior in the female rat (32, 34, 36) . Estrogen-induced PPE gene expression may be directly mediated by an estrogen-ER complex interacting with functional EREs in the PPE promoter region (Zhu et al., Program Abstr., 10th International Congress of Endocrinology, p138, 1996 and unpublished data). ER has been shown to be expressed in the hypothalamus including the VMH (38) , and the ER and PPE genes have been reported to be expressed in the same hypothalamic neurons (39, 40) . Furthermore, specific ERE-like binding activity is detected between the hypothalamic nuclear proteins from female rats and a consensus ERE as well as the putative ERE from the rat PPE promoter region (14) . These complexes contain ER (14) as well as TRs (see Fig. 1 ). All of the TR isoforms are expressed in the rat hypothalamus (41, 42) ; however, the predominant isoforms are TRal and the nonfunctional c-erba2 (41) . In as much as c-erba2 does not bind to T3, and TR,B subtypes do not produce ligand-dependent inhibition of estrogen effect in cotransfection study, we propose that T3 inhibition of estrogen-induced PPE mRNA in VMH of OVX female rats is mediated through TRal, if this interaction occurs in the nuclei of hypothalamic neurons.
Like estrogen-induced lordosis behavior (32) , estrogen induction of PPE mRNA in the VMH and T3 inhibition of the estrogen effect are not dependent on the pituitary (see Fig. 5 ). Furthermore, this T3 inhibition of estrogen-induced gene expression is not due to changes in plasma estradiol concentration, to changes in estrogen bioactivity, or to decreases in hypothalamic ER levels [see accompanying paper (20) ]. Taking these results together, we conclude that T3 inhibition of estrogen-induced hypothalamic gene expression may be mediated directly through liganded ER-TR interaction in-the nuclei of hypothalamic neurons. Finally, T3 inhibition of estrogen induction of hypothalamic gene expression, such as for PPE, may have behavioral consequences. Both exogenous and endogenous T3 display an inhibitory effect on estrogenic induction of lordosis behavior, a well-defined female reproductive behavior in rodents [see accompanying paper (20) ]. These phenomena could relate to the alteration of environmental conditions such as stress, cold temperature, and food availability signaled by thyroid hormones to reproductive function (43) . 
